From targets to treatments: a review of molecular targets in pancreatic neuroendocrine tumors.

@article{Wiedenmann2011FromTT,
  title={From targets to treatments: a review of molecular targets in pancreatic neuroendocrine tumors.},
  author={Bertram Wiedenmann and Matthias Pavel and Beata Kos-Kudla},
  journal={Neuroendocrinology},
  year={2011},
  volume={94 3},
  pages={
          177-90
        }
}
Pancreatic neuroendocrine tumors (pancreatic NET) are relatively rare, slowly growing tumors, although their incidence is increasing, and patients may survive for several years with metastatic disease. Apart from symptomatic relief, there have been few treatment options for these tumors in the past. More recently, investigators have explored the potential of molecularly targeted agents in treating pancreatic NET, with some success. In this review, we consider the data supporting exploitation of… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 21 CITATIONS

Imaging and Screening of Pancreatic Cancer.

  • Radiologic clinics of North America
  • 2017
VIEW 1 EXCERPT
CITES BACKGROUND

Pancreatic tumors in children and young adults with tuberous sclerosis complex

Gonca Koc, Sam Sugimoto, Rachel Kuperman, Bamidele F. Kammen, S. Pinar Karakas
  • Pediatric Radiology
  • 2016
VIEW 1 EXCERPT
CITES BACKGROUND

An uncommon cause of Cushing's syndrome in a 70-year-old man.

  • Hong Kong medical journal = Xianggang yi xue za zhi
  • 2014

References

Publications referenced by this paper.
SHOWING 1-10 OF 133 REFERENCES

Angiopoietin-2 promotes disease progression of neuroendocrine tumors.

  • Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2010